NDRG1 and prostate cancer: A previous study identified ATP1A1A as a potential binding partner of NDRG1 in human prostate cancer cells (Tu et al., 2007), raising the question of whether Ndrg1a physically interacts with ATP1A1A to bring about its downregulation.